Relationships of pain-causing substances with dry skin and effects of zaltoprofen on alleviation of symptoms in arthritis model mice

References

• Feldmann M. Pathogenesis of arthritis: recent research progress. Nat Immunol 2001;2:771–773.
   PubMed Web of Science ®Google Scholar
• Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell 1996;85:307–310.
   PubMed Web of Science ®Google Scholar
• Chua-Aguilera CJ, Möller B, Yawalkar N. Skin manifestations of rheumatoid arthritis, juvenile idiopathic arthritis, and spondyloarthritides. Clin Rev Allergy Immunol 2017;53:371–393.
   PubMed Web of Science ®Google Scholar
• Weisshaar E, Apfelbacher C, Jäger G, et al. Pruritus as a leading symptom: clinical characteristics and quality of life in German and Ugandan patients. Br J Dermatol 2006;155:957–964.
   PubMed Web of Science ®Google Scholar
• Bernardini S, Gravina P, Croce N, et al. Itch gene polymorphisms in healthy population and in patients affected by rheumatoid arthritis and atopic dermatitis. Cell Cycle 2008;7:3607–3609.
   PubMed Web of Science ®Google Scholar
• Morishita N, Ninomiya J, Sei Y, Takiuchi I. Effects of temperature, humidity, minor injury and washing on penetration of dermatophytes into human stratum corneum. Nihon Ishinkin Gakkai Zasshi 2003;44:269–271.
   PubMedGoogle Scholar
• Aoyama H, Tanaka M, Hara M, et al. Nummular eczema: an addition of senile xerosis and unique cutaneous reactivities to environmental aeroallergens. Dermatology 1999;199:135–139.
   PubMed Web of Science ®Google Scholar
• Goto K, Hiramoto K, Kita H, et al. Role of mast cells in the induction of dry skin in a mouse model of rheumatoid arthritis. Cutan Ocul Toxicol 2018;37:61–70.
   PubMed Web of Science ®Google Scholar
• Goto K, Hiramoto K, Kawakita M, et al. The influence of reactive oxygen species and glucocorticoids on dry skin in a mouse model of arthritis. Skin Pharmacol Physiol 2018;31:188–197.
   PubMed Web of Science ®Google Scholar
• Goto K, Hiramoto K, Ooi K. Th2 and Th17 induce dry skin in a mouse model of arthritis. Biol Pharm Bull 2019;42:468–474.
   PubMed Web of Science ®Google Scholar
• Bas DB, Su J, Wigerblad G, et al. Pain in rheumatoid arthritis: models and mechanisms. Pain Manag 2016;6:265–284.
   PubMedGoogle Scholar
• Goto K, Hiramoto K, Takada I, et al. Deterioration of dry skin in arthritis model mice via stress-induced changes in immune cells in the thymus and spleen. J Biosci Med 2020;8:23–37.
   Google Scholar
• Fuchs D, Birklein F, Reeh PW, et al. Sensitized peripheral nociception in experimental diabetes of the rat. Pain 2010;151:496–505.
   PubMed Web of Science ®Google Scholar
• Steckelings UM, Artuc M, Wollschläger T, et al. Angiotensin-converting enzyme inhibitors as inducers of adverse cutaneous reactions. Acta Derm Venereol 2001;81:321–325.
   PubMed Web of Science ®Google Scholar
• Rinaldi G. The itch-scratch cycle: a review of the mechanisms. Dermatol Pract Concept 2019;30:90–97.
   Google Scholar
• Hirate K, Uchida A, Ogawa Y, et al. Zaltoprofen, a non-steroidal anti-inflammatory drug, inhibits bradykinin-induced pain responses without blocking bradykinin receptors. Neurosci Res 2006;54:288–294.
   PubMed Web of Science ®Google Scholar
• Kawai S, Nishida S, Kato M, et al. Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells. Eur J Pharmacol 1998;347:87–94.
   PubMed Web of Science ®Google Scholar
• Tsuji T, Ohtsubo T, Umeyama T, et al. Methods for reducing dacarbazine photodegradation and its accompanying venous pain. Yakugaku Zasshi 2014;134:981–986.
   PubMed Web of Science ®Google Scholar
• Cosgrove KA, Alon G, Bell SF, et al. The electrical effect of two commonly used clinical stimulators on traumatic edema in rats. Phys Ther 1992;72:227–233.
   PubMed Web of Science ®Google Scholar
• Barel AO, Clarys P. Study of the stratum corneum barrier function by transepidermal water loss measurements: comparison between two commercial instruments: evaporimeter and tewameter. Skin Pharmacol 1995;8:186–195.
   PubMedGoogle Scholar
• Berardesca E, European Group for Efficacy Measurements on Cosmetics and Other Topical Products (EEMCO). EEMCO guidance for the assessment of stratum corneum hydration: electrical methods. Skin Res Technol 1997;3:126–132.
   PubMedGoogle Scholar
• Bullock J, Rizvi SAA, Saleh AM, et al. Rheumatoid arthritis: a brief overview of the treatment. Med Princ Pract 2018;27:501–507.
   PubMed Web of Science ®Google Scholar
• Leclerc N, Noh T, Khokhar A, et al. Glucocorticoids inhibit osteocalcin transcription in osteoblasts by suppressing Egr2/Krox20-binding enhancer. Arthritis Rheum 2005;52:929–939.
   PubMedGoogle Scholar
• Hsieh HL, Wang HH, Wu CY, et al. BK-induced COX-2 expression via PKC-delta-dependent activation of p42/p44 MAPK and NF-kappaB in astrocytes. Cell Signal 2007;19:330–340.
   PubMed Web of Science ®Google Scholar
• Averbeck B, Reeh PW. Interactions of inflammatory mediators stimulating release of calcitonin gene-related peptide, substance P and prostaglandin E(2) from isolated rat skin. Neuropharmacology 2001;40:416–423.
   PubMed Web of Science ®Google Scholar
• Olek-Hrab K, Hrab M, Szyfter-Harris J, et al. Pruritus in selected dermatoses. Eur Rev Med Pharmacol Sci 2016;20:3628–3641.
   PubMed Web of Science ®Google Scholar
• Anzelc M, Burkhart CG. Pain and pruritus: a study of their similarities and differences. Int J Dermatol 2020;59:159–164.
   PubMed Web of Science ®Google Scholar
• Cheng X, Zhao L, Ke T, et al. Celecoxib ameliorates diabetic neuropathy by decreasing apoptosis and oxidative stress in dorsal root ganglion neurons via the miR-155/COX-2 axis. Exp Ther Med 2021;22:825.
   PubMed Web of Science ®Google Scholar
• Hu F, Wang X, Pace TW, et al. Inhibition of COX-2 by celecoxib enhances glucocorticoid receptor function. Mol Psychiatry 2005;10:426–428.
   PubMed Web of Science ®Google Scholar
• Casolini P, Catalani A, Zuena AR, et al. Inhibition of COX-2 reduces the age-dependent increase of hippocampal inflammatory markers, corticosterone secretion, and behavioral impairments in the rat. J Neurosci Res 2002;68:337–343.
   PubMed Web of Science ®Google Scholar
• Hakan T, Toklu HZ, Biber N, et al. Effect of COX-2 inhibitor meloxicam against traumatic brain injury-induced biochemical, histopathological changes and blood–brain barrier permeability. Neurol Res 2010;32:629–635.
   PubMed Web of Science ®Google Scholar
• Guevara C, Fernandez AC, Cardenas R, et al. Reduction of spinal PGE2 concentrations prevents swim stress-induced thermal hyperalgesia. Neurosci Lett 2015;591:110–114.
   PubMed Web of Science ®Google Scholar
• Fernandes E, Costa D, Toste SA, et al. In vitro scavenging activity for reactive oxygen and nitrogen species by nonsteroidal anti-inflammatory indole, pyrrole, and oxazole derivative drugs. Free Radic Biol Med 2004;37:1895–1905.
   PubMed Web of Science ®Google Scholar
• Ständer S, Schmelz M. Chronic itch and pain–similarities and differences. Eur J Pain 2006;10:473–478.
   PubMed Web of Science ®Google Scholar
• Ständer S, Luger TA. NK-1 antagonists and itch. Handb Exp Pharmacol 2015;226:237–255.
   PubMedGoogle Scholar
• Jeong HJ, Oh HA, Lee BJ, et al. Inhibition of IL-32 and TSLP production through the attenuation of caspase-1 activation in an animal model of allergic rhinitis by Naju Jjok (Polygonum tinctorium). Int J Mol Med 2014;33:142–150.
   PubMed Web of Science ®Google Scholar
• Wu D, Yuan P, Ke C, et al. Salidroside suppresses solar ultraviolet-induced skin inflammation by targeting cyclooxygenase-2. Oncotarget 2016;7:25971–25982.
   PubMedGoogle Scholar
• Higuchi T, Takeuchi A, Munesue S, et al. Anti-tumor effects of a nonsteroidal anti-inflammatory drug zaltoprofen on chondrosarcoma via activating peroxisome proliferator-activated receptor gamma and suppressing matrix metalloproteinase-2 expression. Cancer Med 2018;7:1944–1954.
   PubMed Web of Science ®Google Scholar
• Yamazaki R, Kusunoki N, Matsuzaki T, et al. Nonsteroidal anti-inflammatory drugs induce apoptosis in association with activation of peroxisome proliferator-activated receptor gamma in rheumatoid synovial cells. J Pharmacol Exp Ther 2002;302:18–25.
   PubMed Web of Science ®Google Scholar
• Maruyama K, Goto K, Hiramoto K, et al. Indomethacin, a non-steroidal anti-inflammatory drug, induces skin dryness via PPARγ in mice. Biol Pharm Bull 2022;45:77–85.
   PubMed Web of Science ®Google Scholar
• Cho IJ, Lee CW, Lee MY, et al. Differential anti-inflammatory and analgesic effects by enantiomers of zaltoprofen in rodents. Int Immunopharmacol 2013;16:457–460.
   PubMed Web of Science ®Google Scholar
• Myśliwiec H, Baran A, Harasim-Symbor E, et al. Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients. Arch Dermatol Res 2017;309:79–86.
   PubMed Web of Science ®Google Scholar
• Jensen JM, Fölster-Holst R, Baranowsky A, et al. Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J Invest Dermatol 2004;122:1423–1431.
   PubMed Web of Science ®Google Scholar
• Migita K, Honda S, Yamasaki S, et al. Regulation of rheumatoid synovial cell growth by ceramide. Biochem Biophys Res Commun 2000;269:70–75.
   PubMed Web of Science ®Google Scholar